Loading...
PhD Urša Lampreht Tratar

PhD Urša Lampreht Tratar
no.: 36367 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
4.04.03  Biotechnical sciences  Veterinarian medicine  Therapy and health prevention of animals 
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
232.74
A''
0
A'
128.59
A1/2
180.55
CI10
423
CImax
116
h10
12
A1
0.83
A3
0.11
Data for the last 5 years (citations for the last 10 years) on February 25, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 34  516  335  9.85 
Scopus 32  599  420  13.13 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,158 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,858 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,792 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,043 
5. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,423 
6. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,872 
7. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  5,984 
8. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2024  PhD Metka Novak  1,741 
9. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   2021 - 2024  PhD Anže Smole  2,460 
10. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,688 
11. J3-2529  Role of endothelium in tumor response to radiotherapy   2022 - 2023  PhD Boštjan Markelc  3,290 
12. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2022 - 2023  PhD Mateja Erdani Kreft  5,079 
13. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,133 
14. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   2020 - 2023  PhD Nataša Tozon  3,504 
15. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,445 
16. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2018  PhD Maja Čemažar  3,489 
17. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,218 
18. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,039 
19. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,665 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0428  Comparative oncology for tackling rare cancers   2023 - 2024  PhD Ario de Marco  881 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2023  PhD Gregor Serša  3,885 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,219 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2013 - 2014  PhD Gregor Serša  3,969 
We were not given permission by the researcher to publish data.
Views history
Favourite